Key findings 

Randomised controlled trials of drugs for rheumatoid arthritis commonly exclude patients older than 65 years, according to a study conducted by Polish investigators and reported in the journal Rheumatology .

Implications

Limited safety and efficacy data applicable to the rapidly growing population of geriatric patients living with this ...